SAN DIEGO, October 26, 2023 – ResMed Inc. (NYSE: RMD, ASX: RMD) announced results for its
quarter ended September 30, 2023.
First Quarter 2024 Highlights
All comparisons are to the prior year period
• Revenue increased by 16% to $1.1 billion; up 15% on a constant currency basis
• Gross margin contracted 250 bps to 54.4%; non-GAAP gross margin contracted 160 bps to 56.0%
• Income from operations increased 5%; non-GAAP operating profit up 10%
• Operating cash flow of $286.3 million
• Diluted earnings per share of $1.49; non-GAAP diluted earnings per share of $1.64
Buy RMD now and get great upside returns in a year or two, page-4
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$33.10 |
Change
0.400(1.22%) |
Mkt cap ! $21.12B | |||
| Open | High | Low | Value | Volume |
| $33.05 | $33.26 | $32.90 | $50.44M | 1.523M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 318 | $33.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $33.12 | 3701 | 3 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$33.09 |
Change
0.400 ( 1.13 %) |
||||
| Open | High | Low | Volume | ||
| $32.91 | $33.26 | $32.91 | 699224 | ||
| Last updated 15.59pm 16/05/2024 ? | |||||
| RMD (ASX) Chart |